Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Almirall, Eli Lilly, Fosun Kite, Genmab, Gilead Sciences, Jiangsu Recbio Technology, Kite, Outlook, Pharming.